Acute Leukemia News

  • Seattle Genetics Halts Late-stage Study of Leukemia Drug Seattle Genetics Inc said it would halt a late-stage study of its drug to treat a type of leukemia in older patients following a "higher rate" of deaths in patients on the drug compared with those on a placebo.
  • Cancer Agency Left in the Dark Over Glyphosate Evidence When Aaron Blair sat down to chair a week-long meeting of 17 specialists at the International Agency for Research on Cancer in France in March 2015, there was something he wasn't telling them.
 

Acute Leukemia Perspective

 

Acute Leukemia Journal Articles